← All trials
NCT00903006
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2009
- Primary completion
- May 1, 2013
- Completion date
- May 1, 2013
- First posted
- —
- Last posted
- —
- Enrollment
- 11
- Arms / groups
- 4 / —
- Source
- AACT · pre-existing
Sponsors
- University of Texas at HoustonLead sponsor
- MerckCollaborator
- Bristol-Myers SquibbCollaborator
- Commonwealth Foundation for Cancer ResearchCollaborator
- University of Texas at HoustonStudy chair
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.